With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting MYCN||Children's Hospital of Philadelphia / Yael Mossé, MD & Julie Park, MD||Crazy 8 Initiative||2019||Pennsylvania|
|A comprehensive public resource for fusion-negative sarcoma sequencing data||University of California San Francisco / Alejandro Sweet-Cordero, MD & Richard Gorlick, MD||Crazy 8 Initiative||2019||California|
|Live-Cell Surface Proteomic Characterization of Atypical Teratoid Rhabdoid Tumors Using High Throughout Multi-Color Flow||University of Colorado Denver / Siddhartha S. Mitra, PhD||Crazy 8 Initiative||2019||Colorado|
|Cell Line and Xenograft Repository||Texas Tech University Health Sciences Center / Patrick Reynolds, MD/PhD||Catalyst Grants||2014||Texas|
|Targeting Spinal Ependymoma and Other Gliomas Using Novel Genetically Defined Models||The Johns Hopkins University School of Medicine / Charles Eberhart, MD, PhD||Catalyst Grants||2019||Maryland|
|Restoring RUNX1 Levels in FPD/AML||University of Washington, Seattle / Marshall Horwitz, MD/PhD||Familial RUNX1 Research Grants||2016||Washington|
|Characterization of Pre-Leukemia Associated with Familial RUNX1 Mutations||Stanford University / Ravi Majeti, MD/PhD||Familial RUNX1 Research Grants||2016||California|
|Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models||Icahn School of Medicine at Mount Sinai / Eirini Papapetrou, MD/PhD||Familial RUNX1 Research Grants||2016||New York|
|Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML||Boston Children's Hospital / Alan Cantor, MD, PhD||Familial RUNX1 Research Grants||2016||Massachusetts|
|Role of Inflammatory Microenvironment in Clonal evolution and Progression from FPD to AML||Oregon Health & Science University / Anupriya Agarwal, PhD||Familial RUNX1 Research Grants||2017||Oregon|